Immatics Stock Performance

IMTX
 Stock
  

USD 10.07  0.07  0.70%   

On a scale of 0 to 100, Immatics holds a performance score of 4. The company retains a Market Volatility (i.e., Beta) of 0.4446, which attests to possible diversification benefits within a given portfolio. Let's try to break down what Immatics's beta means in this case. As returns on the market increase, Immatics returns are expected to increase less than the market. However, during the bear market, the loss on holding Immatics will be expected to be smaller as well. Although it is vital to follow Immatics NV current price history, it is good to be conservative about what you can do with the information regarding equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating Immatics NV technical indicators, you can presently evaluate if the expected return of 0.27% will be sustainable into the future. Please utilizes Immatics maximum drawdown, as well as the relationship between the skewness and day typical price to make a quick decision on whether Immatics NV current trending patterns will revert.
  
Immatics Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Immatics NV are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Immatics showed solid returns over the last few months and may actually be approaching a breakup point. ...more

Immatics Price Channel

Quick Ratio2.78
Fifty Two Week Low5.75
Target High Price30.08
Fifty Two Week High14.90
Target Low Price14.04

Immatics Relative Risk vs. Return Landscape

If you would invest  896.00  in Immatics NV on July 5, 2022 and sell it today you would earn a total of  111.00  from holding Immatics NV or generate 12.39% return on investment over 90 days. Immatics NV is currently generating 0.2671% in daily expected returns and assumes 4.2225% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Immatics, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Immatics is expected to generate 3.66 times more return on investment than the market. However, the company is 3.66 times more volatile than its market benchmark. It trades about 0.06 of its potential returns per unit of risk. The DOW is currently generating roughly -0.07 per unit of risk.

Immatics Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Immatics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Immatics NV, and traders can use it to determine the average amount a Immatics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0633

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsIMTX
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 4.22
  actual daily
 
 36 %
of total potential
 
3636
Expected Return
 0.27
  actual daily
 
 5 %
of total potential
 
55
Risk-Adjusted Return
 0.06
  actual daily
 
 4 %
of total potential
 
44
Based on monthly moving average Immatics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immatics by adding it to a well-diversified portfolio.

About Immatics Performance

To evaluate Immatics NV Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Immatics generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Immatics Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Immatics NV market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Immatics's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 373 people.

Things to note about Immatics NV

Checking the ongoing alerts about Immatics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Immatics NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Immatics Alerts

Equity Alerts and Improvement Suggestions

Immatics NV has very high historical volatility over the last 90 days
About 36.0% of the company shares are held by company insiders
Latest headline from www.nasdaq.com: Further weakness as Immatics drops 11 percent this week, taking one-year losses to 26 percent - Nasdaq
Please see Risk vs Return Analysis. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for analysis

When running Immatics NV price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Is Immatics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine Immatics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.